The Second Wave of Clinical Mobility: Strategic Solution Investments for Mobile Point of Care in Western Europe

The Second Wave of Clinical Mobility: Strategic Solution Investments for Mobile Point of Care in Western Europe
Sponsored by: Intel Corporation.
The highly collaborative and mobile nature of clinical teams makes the strategic investment in clinical mobility solutions essential to meet the intense demands being placed on healthcare providers today. Many of the same drivers - the need to improve access, quality of care, patient safety, and clinician efficiency to treat more patients cost-effectively - are setting in motion the second wave of clinical mobility. Sometimes referred to as mobile point of care (MPOC) computing, today's initiatives enable clinicians to use various mobile devices to access electronic health records (EHRs) and other clinical information systems at the bedside, in the examination room, or from wherever the clinician accesses the Internet.

The next 10 years represent the second wave of clinical mobility. With the consumerization of technology and greater uptake of mobile devices by clinicians who want to use them as they care for their patients, mobile applications will evolve from providing basic views only to bidirectional flows of information enabling better decision making at the point of care and more synchronous communication and collaboration between care team members.

Download from eHealthNews.eu Portal's mirror: The Second Wave of Clinical Mobility: Strategic Solution Investments for Mobile Point of Care in Western Europe (.pdf, 801 KB).

About IDC Health Insights
IDC Health Insights provides research-based advisory and consulting services that enable healthcare and life science executives to:

  • Maximize the business value of their technology investments
  • Minimize technology risk through accurate planning
  • Benchmark themselves against industry peers
  • Adopt industry best practices for business/technology alignment
  • Make more informed technology decisions and drive technology-enabled business innovation

IDC Health Insights provides full coverage of the health industry value chain and closely follows the payer, provider, and life science segments. Its particular focus is on developing and employing strategies that leverage IT investments to maximize organizational performance. Staffed by senior analysts with significant technology experience in the healthcare industry, IDC Health Insights provides a portfolio of offerings that are relevant to both IT and business needs.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...